Clinical and Experimental Vaccine Research

  • 제11권3호
  • /
  • Pages.290-293
  • /
  • 2022
  • /
  • 2287-3651(pISSN)
  • /
  • 2287-366X(eISSN)
대한백신학회 (The Korean Vaccine Society)
권호 표지
DOI QR코드

DOI QR Code

Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports

  • Giuseppe Lassandro (Department Interdisciplinary of Medicine, Pediatric Unit "B. Trambusti", University of Bari "Aldo Moro") ;
  • Francesco Carriero (Department Interdisciplinary of Medicine, Pediatric Unit "B. Trambusti", University of Bari "Aldo Moro") ;
  • Valentina Palladino (Department Interdisciplinary of Medicine, Pediatric Unit "B. Trambusti", University of Bari "Aldo Moro") ;
  • Giovanni Carlo Del Vecchio (Department Interdisciplinary of Medicine, Pediatric Unit "B. Trambusti", University of Bari "Aldo Moro") ;
  • Paola Giordano (Department Interdisciplinary of Medicine, Pediatric Unit "B. Trambusti", University of Bari "Aldo Moro")
  • 투고 : 2022.01.02
  • 심사 : 2022.04.30
  • 발행 : 2022.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. Many viruses and some vaccines have been identified as triggering the autoimmune process, including parvovirus, human immunodeficiency virus, Epstein-Barr virus, rubella, and measles. However, ITP in association with coronavirus disease 2019 (COVID-19) vaccination has not been reported so far. We describe the cases of two young girls affected by ITP presenting a quick reduction of platelet count after receiving Pfizer-BioNTech COVID-19 vaccine.

키워드

참고문헌

  1. Giordano P, Lassandro G, Giona F, et al. ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's. Pediatr Hematol Oncol 2014;31:534-47. 
  2. Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus 2014;23:554-67. 
  3. Audia S, Mahevas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B. Immune thrombocytopenia: recent advances in pathogenesis and treatments. Hemasphere 2021;5:e574. 
  4. Lassandro G, Palladino V, Amoruso A, Palmieri VV, Russo G, Giordano P. Children in coronaviruses' wonderland: what clinicians need to know. Mediterr J Hematol Infect Dis 2020;12:e2020042. 
  5. Lassandro G, Palladino V, Palmieri VV, Amoruso A, Del Vecchio GC, Giordano P. COVID-19 and children with immune thrombocytopenia: emerging issues. Mediterr J Hematol Infect Dis 2020;12:e2020028. 
  6. Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): Emergency Use Authorization (EUA) of the Pfizer-BioN-Tech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). Silver Spring (MD): Food and Drug Administration; 2020. 
  7. Magdi M, Rahil A. Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: a case report and literature review. Eur J Case Rep Intern Med 2019;6:001155. 
  8. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol 2021;96:534-7. 
  9. Giordano P, Lassandro G, Barone A, et al. Use of eltrombopag in children with chronic immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Front Med (Lausanne) 2020;7:66. 
  10. Giordano P, Cascioli S, Lassandro G, et al. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy. Pediatr Res 2016;79:262-70. 
  11. McCrae K. Immune thrombocytopenia: no longer 'idiopathic'. Cleve Clin J Med 2011;78:358-73. 
  12. Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med 2020;2:2048-58. 
  13. Perricone C, Ceccarelli F, Nesher G, et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res 2014;60:226-35. 
  14. Saudagar V, Patil S, Goh S, Pothiawala S. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine. Ir J Med Sci 2022;191:919-20. 
  15. Giordano P, Lassandro G, di Meo NA, et al. A narrative approach to describe QoL in children with chronic ITP. Front Pediatr 2019;7:163.